Syllable is a California-based SaaS platform that provides solutions such as AI-driven patient assistance and help desk management for the healthcare industry.
$40M
Apr 24, 2022
-
Zephyr AI is a Virginia-based health-tech platform that offers solutions such as AI-driven drug discovery and clinical decision analysis for sectors including pharma and biotech.
$18.5M
Mar 29, 2022
-
Culture Biosciences is a California-based biotech research firm that provides services such as clone structure screening and process model development for biopharma companies.
$80M
Oct 13, 2021
-
PHC is a California-based SaaS platform that provides disease detection, prevention and related solutions for healthcare and government organizations.
$8M
Apr 29, 2021
-
Frequently Asked Questions about Verily
What is Verily investing in?
Verily has invested in 11 companies including Nusano, Syllable and Zephyr AI
What company did Verily invest in?
Verily invested in a total 11 companies including Nusano, Syllable and Zephyr AI
What are the top 5 investments by Verily?
The top companies in which Verily invested are Nusano, Syllable, Zephyr AI, Culture Biosciences and The Public Health Company Group Inc
